Literature DB >> 16880823

MAPK signalling: ERK5 versus ERK1/2.

Satoko Nishimoto1, Eisuke Nishida.   

Abstract

Extracellular-signal-regulated kinase 5 (ERK5) is a member of the mitogen-activated protein kinase (MAPK) family and, similar to ERK1/2, has the Thr-Glu-Tyr (TEY) activation motif. Both ERK5 and ERK1/2 are activated by growth factors and have an important role in the regulation of cell proliferation and cell differentiation. Moreover, both the ERK5 and the ERK1/2 pathways are sensitive to PD98059 and U0126, which are two well-known inhibitors of the ERK pathway. Despite these similarities, recent studies have revealed distinctive features of the ERK5 pathway: ERK5 has a key role in cardiovascular development and neural differentiation; ERK5 nuclear translocation is controlled by its own nuclear localizing and nuclear export activities; and the carboxy-terminal half of ERK5, which follows its kinase catalytic domain, has a unique function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880823      PMCID: PMC1525153          DOI: 10.1038/sj.embor.7400755

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  72 in total

1.  PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.

Authors:  E Formstecher; J W Ramos; M Fauquet; D A Calderwood; J C Hsieh; B Canton; X T Nguyen; J V Barnier; J Camonis; M H Ginsberg; H Chneiweiss
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

Review 2.  Control of MAP kinase signaling to the nucleus.

Authors:  Kunio Kondoh; Satoru Torii; Eisuke Nishida
Journal:  Chromosoma       Date:  2005-05-18       Impact factor: 4.316

Review 3.  Regulation of cellular functions by the ERK5 signalling pathway.

Authors:  Xin Wang; Cathy Tournier
Journal:  Cell Signal       Date:  2006-01-06       Impact factor: 4.315

4.  Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.

Authors:  Satoko Nishimoto; Morioh Kusakabe; Eisuke Nishida
Journal:  EMBO Rep       Date:  2005-09-23       Impact factor: 8.807

5.  The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.

Authors:  Kimberly L Dodge-Kafka; Joseph Soughayer; Genevieve C Pare; Jennifer J Carlisle Michel; Lorene K Langeberg; Michael S Kapiloff; John D Scott
Journal:  Nature       Date:  2005-09-22       Impact factor: 49.962

6.  PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation.

Authors:  Kazuhiro Nakamura; Mark T Uhlik; Nancy L Johnson; Klaus M Hahn; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

7.  Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2.

Authors:  Azucena Esparís-Ogando; Elena Díaz-Rodríguez; Juan Carlos Montero; Laura Yuste; Piero Crespo; Atanasio Pandiella
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

8.  Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals.

Authors:  Gray W Pearson; Svetlana Earnest; Melanie H Cobb
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms.

Authors:  Kunio Kondoh; Kazuya Terasawa; Hiroko Morimoto; Eisuke Nishida
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

10.  A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway.

Authors:  Jan Seyfried; Xin Wang; Giorgi Kharebava; Cathy Tournier
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

View more
  136 in total

1.  Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Authors:  Allyson Booth; Tammy Trudeau; Crystal Gomez; M Scott Lucia; Arthur Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  2014-12

Review 2.  Control of mitochondrial activity by miRNAs.

Authors:  Peifeng Li; Jianqing Jiao; Guifeng Gao; Bellur S Prabhakar
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

3.  Tie1 deficiency induces endothelial-mesenchymal transition.

Authors:  Julie Garcia; Maria José Sandi; Pierre Cordelier; Bernard Binétruy; Jacques Pouysségur; Juan Lucio Iovanna; Roselyne Tournaire
Journal:  EMBO Rep       Date:  2012-05-01       Impact factor: 8.807

Review 4.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

5.  Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.

Authors:  Chang Su; Rebecca L Cunningham; Nataliya Rybalchenko; Meharvan Singh
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

6.  A sharper instrument for dissecting signalling events: a specific AGC kinase inhibitor.

Authors:  Christopher G Proud
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

7.  Signaling in H2O2-induced increase in cell proliferation in Barrett's esophageal adenocarcinoma cells.

Authors:  Xiaoxu Zhou; Dan Li; Murray B Resnick; Jose Behar; Jack Wands; Weibiao Cao
Journal:  J Pharmacol Exp Ther       Date:  2011-07-12       Impact factor: 4.030

Review 8.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

9.  Beta-like importins mediate the nuclear translocation of mitogen-activated protein kinases.

Authors:  Eldar Zehorai; Rony Seger
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

Review 10.  The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.

Authors:  Sachchida Nand Rai; Hagera Dilnashin; Hareram Birla; Saumitra Sen Singh; Walia Zahra; Aaina Singh Rathore; Brijesh Kumar Singh; Surya Pratap Singh
Journal:  Neurotox Res       Date:  2019-02-01       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.